Mobile Blog Overview Mobile Blog Overview

Generic Lipitor recalled again

December 5, 2012

Do You Have a Case?

Find Out Now >

December 5, 2012

Three months ago, generic Lipitor was recalled by Ranbaxy because of possible mispackaging. Last week, it was again recalled by Ranbaxy Laboratories, an Indian generics plant, because of glass particles getting into the pills, according to Fierce Pharma.

Forty-one lots of atorvastin (Lipitor) in the 10, 20, and 40 mg sizes have been recalled and production halted. Ranbaxy had about 40 percent of the U.S. market for the drug.

Although the FDA says that the danger is small and no problems have been reported, the website Prevent Medical Error provides more detail than the company or the FDA. It says that Ranbaxy found foreign particles in a "powder" used for making the pills. Then the company discovered a "quarter-sized piece of the glass housing used during manufacturing was found to be missing. It was presumed that this piece of glass fell into the powder during the manufacturing process."

The FDA said that Ranbaxy has now stopped production until it gets to the bottom of its problems.

In August, the company notified retail customers that it was recalling a single lot of 10 mg atorvastatin after a customer reported finding a 20 mg tablet in a 10 mg bottle. The plant then voluntarily recalled the pills.

If you or someone you love has suffered a drug injury, the Ohio personal injury lawyers at Nurenberg, Paris, Heller & McCarthy may be able to help.

Related Posts